Daniel M. Halperin
Impact in
Papers in
- Epidemiology 79
- Neuroendocrine Tumor Research Advances 77
- Oncology 78
- Lung Cancer Research Studies 63
- Pancreatic and Hepatic Oncology Research 11
- Cancer Immunotherapy and Biomarkers 4
- Co-authors
- James C. Yao (42 shared papers)Arvind Dasari (32 shared papers)Chan Shen (7 shared papers)Ya‐Chen Tina Shih (8 shared papers)Shouhao Zhou (7 shared papers)Ying Xu (6 shared papers)Bo Zhao (1 shared paper)Kevin J. Tracey (1 shared paper)
- Journals
- Journal of Clinical Oncology (22 papers)Pancreas (8 papers)Annals of Oncology (6 papers)Endocrine Related Cancer (4 papers)Clinical Cancer Research (2 papers)
- Partner nations
- United StatesCanadaUnited Kingdom
In The Last Decade
Daniel M. Halperin
97 papers receiving 4.2k citations
Daniel M. Halperin's Hit Papers
Peers
Comparison fields: 5 of 107
- Neurology 2.1k
- Oncology 3.1k
- Epidemiology 3.4k
- Clinical Biochemistry 257
- Gastroenterology 161
Countries citing papers authored by Daniel M. Halperin
This map shows the geographic impact of Daniel M. Halperin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daniel M. Halperin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daniel M. Halperin more than expected).
Fields of papers citing papers by Daniel M. Halperin
This network shows the impact of papers produced by Daniel M. Halperin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daniel M. Halperin. The network helps show where Daniel M. Halperin may publish in the future.
Co-authors
The 25 scholars most cited alongside Daniel M. Halperin, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 102 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Trends in the Incidence, Prevalence, and Survival Outcomes in Patients With Neuroendocrine Tumors in the United States Hit paper breakdown → | 2017 | 2321 |
| 2 | Ethyl pyruvate prevents lethality in mice with established lethal sepsis and systemic inflammation Hit paper breakdown → | 2002 | 510 |
| 3 | 2017 | 248 | |
| 4 | 2020 | 115 | |
| 5 | 2015 | 99 | |
| 6 | 2020 | 85 | |
| 7 | 2017 | 43 | |
| 8 | 2017 | 38 | |
| 9 | 2024 | 32 | |
| 10 | 2016 | 31 | |
| 11 | 2018 | 31 | |
| 12 | 2020 | 30 | |
| 13 | 2019 | 28 | |
| 14 | 2015 | 26 | |
| 15 | 2014 | 22 | |
| 16 | 2014 | 21 | |
| 17 | 2020 | 20 | |
| 18 | 2019 | 19 | |
| 19 | 2018 | 19 | |
| 20 | 2020 | 19 |
About Daniel M. Halperin
Daniel M. Halperin is a scholar working on Epidemiology, Oncology, Neurology, Surgery and Cancer Research, having authored 102 papers that have together received 4.2k indexed citations. Recurring topics across this work include Neuroendocrine Tumor Research Advances (77 papers), Lung Cancer Research Studies (63 papers), Neuroblastoma Research and Treatments (59 papers), Pancreatic and Hepatic Oncology Research (11 papers), Cancer Immunotherapy and Biomarkers (4 papers), Cancer Genomics and Diagnostics (4 papers), Health Systems, Economic Evaluations, Quality of Life (4 papers) and Colorectal and Anal Carcinomas (4 papers). The work is most often cited by research in Neurology (2.1k citations), Oncology (3.1k citations), Epidemiology (3.4k citations), Clinical Biochemistry (257 citations) and Gastroenterology (161 citations). Daniel M. Halperin has collaborated with scholars based in United States, Canada and United Kingdom. Frequent co-authors include James C. Yao, Arvind Dasari, Chan Shen, Ya‐Chen Tina Shih, Shouhao Zhou, Ying Xu, Bo Zhao, Kevin J. Tracey, Mahendar Ochani and Mitchell P. Fink. Their work appears in journals such as Journal of Clinical Oncology, Pancreas, Annals of Oncology, Endocrine Related Cancer and Clinical Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.